We found that the proportion of Macro_APOE/CTSZ was significantly higher in tumor than normal tissues (Fig. 3A,B) and accounted for more than 20% of macrophages in most CRC patients (Fig. 3C). This evidence concerns the gene CTSZ and colorectal carcinoma.